Visiting Scientist, Division of Neurotoxicology
Hector Rosas-Hernandez, Ph.D.
Dr. Rosas-Hernandez received a B.S. in biology and chemistry from the Universidad Autonoma de San Luis Potosi, Mexico in 2008. He then received an M.S. and a Ph.D. in Bioprocesses from the same university, in 2011 and 2015 respectively. In his Ph.D. work, Dr. Rosas-Hernandez discovered that the hormone prolactin regulates the function of the blood-brain barrier, both in vitro and in vivo. In 2015 he was awarded an ORISE postdoctoral fellowship in the Division of Neurotoxicology at NCTR. During his postdoctoral training, he developed in vitro models of traumatic brain injury (TBI) based on stretch-induced deformation of cells in culture. Using these methods, he studied the effects of TBI on the blood-brain barrier and dopaminergic systems, demonstrating that stretch injury can be used to replicate the effects of TBI in an in vitro setting. In 2018, Dr. Rosas-Hernandez became a Visiting Scientist in the Division of Neurotoxicology, where his work is focused on the experimental modeling of TBI. Dr. Rosas-Hernandez has received multiple awards, including: the Hispanic Organization of Toxicologists Travel Award in 2013, the International Brain Research Organization Travel Award in 2014 and 2015, and the NCTR Director’s Publication Award to a Junior Scientist in 2019.
Dr. Rosas-Hernandez’s research interests include experimental modeling focused on the development of neurodegenerative disorders after TBI. Dr. Rosas-Hernandez is also interested in investigating the vascular dysfunction in TBI and Alzheimer’s disease, specifically the contribution of the blood-brain barrier to these pathologies. He is also studying the role of exosomes in the propagation of Alzheimer’s and Parkinson’s disease and has a particular interest in the use of novel technologies (i.e. microphysiological systems) to model the blood-brain barrier in vitro.
Professional Societies/National and International Groups
National System of Researchers of Mexico
Member (Level I)
Society for Neuroscience
Stretch-Induced Deformation as a Model to Study Dopaminergic Dysfunction in Traumatic Brain Injury.
Rosas-Hernandez H., Burks S.M., Cuevas E. and Ali S.F.
Neurochem Res. 2019, doi: 10.1007/s11064-019-02872-8. [Epub ahead of print].
Amyloid Beta 25-35 Induces Blood-Brain Barrier Disruption In Vitro.
Cuevas E., Rosas-Hernandez H., Burks S.M., Ramirez-Lee M.A., Guzman A., Imam S.Z., Ali S.F. and Sarkar S.
Metab Brain Dis. 2019, 34(5):1365-1374. doi: 10.1007/s11011-019-00447-8. [Epub 2019 Jul 2].
Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer's Disease.
Rosas-Hernandez H., Cuevas E., Raymick J.B., Robinson B.L., Ali S.F., Hanig J. and Sarkar S.
Curr Alzheimer Res. 2019, 16(5):388-395. doi: 10.2174/1567205016666190321155422.
Identification of Altered MicroRNAs in Serum of a Mouse Model of Parkinson's Disease.
Rosas-Hernandez H., Chigurupati S., Raymick J., Robinson B., Cuevas E., Hanig J. and Sarkar S.
Neurosci Lett. 2018, 687:1-9. doi: 10.1016/j.neulet.2018.07.022. [Epub 2018 Jul 17].
Characterization of Uniaxial High-Speed Stretch as an In Vitro Model of Mild Traumatic Brain Injury on the Blood-Brain Barrier.
Rosas-Hernandez H., Cuevas E., Escudero-Lourdes C., Lantz S.M., Sturdivant N.M., Imam S.Z., Sarkar S., Slikker W. Jr., Paule M.G., Balachandran K. and Ali S.F.
Neurosci Lett. 2018, 672:123-129. doi: 10.1016/j.neulet.2018.02.019. [Epub 2018 Feb 16].
Isolation and Culture of Brain Microvascular Endothelial Cells for In Vitro Blood-Brain Barrier Studies.
Rosas-Hernandez H., Cuevas E., Lantz S.M., Paule M.G. and Ali S.F.
Methods Mol Biol. 2018, 1727:315-331. doi: 10.1007/978-1-4939-7571-6_23.
Characterization of Biaxial Stretch as an In Vitro Model of Traumatic Brain Injury to the Blood-Brain Barrier.
Rosas-Hernandez H., Cuevas E., Escudero-Lourdes C., Lantz S.M., Gomez-Crisostomo N.P., Sturdivant N.M., Balachandran K., Imam S.Z., Slikker W. Jr., Paule M.G. and Ali S.F.
Mol Neurobiol. 2018, 55(1):258-266. doi: 10.1007/s12035-017-0738-5.
Inhibition of Prolactin with Bromocriptine for 28 Days Increases Blood-Brain Barrier Permeability in the Rat.
Rosas-Hernandez H., Ramirez M., Ramirez-Lee M.A., Ali S.F. and Gonzalez C.
Neuroscience. 2015, 301:61-70. doi: 10.1016/j.neuroscience.2015.05.066. [Epub 2015 Jun 3].
- Contact Information
- Hector Rosas-Hernandez